Patents by Inventor Katrien Lorre

Katrien Lorre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
    Publication number: 20070031377
    Abstract: The present invention relates to preventing, or treating and/or reducing the severity or progression of Type 1 immune response-mediated inflammatory lung disease. More particularly, the present invention provides a method for preventing or treating chronic obstructive pulmonary disease (COPD), severe asthma, sarcoidosis, berylliosis or cystic fibrosis by neutralizing or reducing IFN? bioactivity which can be achieved either by in vivo administration of IFN? neutralizing molecules or by in vivo immunization with pharmaceutical compositions comprising immunogenic IFN? proteins or IFN?-derived (poly)peptides or their corresponding nucleic acid sequences.
    Type: Application
    Filed: March 26, 2004
    Publication date: February 8, 2007
    Inventors: Stany Depraetere, Katrien Lorre, Marie-Ange Buyse
  • Use of primate IFN-gamma binding molecules
    Publication number: 20030211103
    Abstract: The present invention relates to the therapeutic use of molecules which bind and neutralize IFN-&ggr; in primates. More specifically, the present invention relates to the use of an anti-primate IFN-&ggr; antibody for preventing or treating diseases wherein IFN-&ggr; is pathogenic. The present invention further relates to a pharmaceutical composition comprising the anti-primate IFN-&ggr; antibody D9D10 for preventing or treating pathological reactions caused by IFN-&ggr;.
    Type: Application
    Filed: April 28, 2003
    Publication date: November 13, 2003
    Inventors: Marie-Ange Buyse, Katrien Lorre